XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 25, 2022
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the six months ended June 25, 2022 was as follows:

 

       Weighted Average 
   Shares   Grant Fair Value 
Balance, December 25, 2021   2,077,592   $2.90 
Granted   186,500    1.53 
Forfeited   (234,948)   2.61 
Vested   (204,421)   3.80 
Balance, June 25, 2022   1,824,723   $2.70 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and six months ended June 25, 2022 and June 26, 2021 (no tax benefits were recognized):

 

                     
   Three Months Ended   Three Months Ended  

Six Months

Ended

   Six Months
Ended		 
   June 25, 2022   June 26, 2021   June 25, 2022   June 26, 2021 
Cost of product revenues  $11,713   $34,789   $78,381   $168,573 
Research and development   108,347    121,012    255,726    215,065 
Selling, general and administrative   296,973    358,708    738,999    2,741,037 
Total  $417,033   $514,509   $1,073,106   $3,124,675